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Introduction {#sec001}
============

Although mutagenesis is a prerequisite for evolution, mutations are also life threatening as they are at the basis of inborn diseases and age-related pathologies such as cancer. To sustain genetic integrity several mechanisms have evolved that restrict the level of mutation induction. For example, during DNA replication, the combined action of proofreading activity of the replicative polymerases and the mismatch repair pathway provides an estimated 10.000-fold increase in copying accuracy \[[@pgen.1008759.ref001],[@pgen.1008759.ref002]\]. Apart from errors during replication of non-damaged DNA, mutations can also result from incorporation of nucleotides across damaged bases that are caused by exogenous sources or endogenous processes within the cell. For example, oxidative metabolites can react with DNA, which then hampers DNA replication \[[@pgen.1008759.ref003]\]. Efficient and unperturbed DNA synthesis is nevertheless essential for maintaining genetic integrity because persistent replication impairment can lead to under-replicated areas of the genome, and the formation of highly toxic DNA double-strand breaks (DSBs) that may result in genomic rearrangements or cell death. Such detrimental outcomes are profoundly suppressed by the action of the excision repair pathways base excision repair (BER) and nucleotide excision repair (NER), which can replace the damaged bases, thereby preventing these from becoming replication obstacles \[[@pgen.1008759.ref003],[@pgen.1008759.ref004]\]. DNA damage can, however, also be bypassed through so-called DNA damage tolerance pathways, in which lesions are left unrepaired, yet replication of the genome is completed, hence ensuring cell cycle progression \[[@pgen.1008759.ref005]\]. A well-studied mechanism to tolerate DNA damage is translesion synthesis (TLS). Despite the potential of replicative polymerases to bypass certain DNA lesions (*e*.*g*. \[[@pgen.1008759.ref006]\]) they are blocked by a plethora of damaged bases, and specialized TLS polymerases are required to synthesize DNA opposite these impediments. Lesions can be bypassed directly when the replicative polymerase is temporarily exchanged for a TLS polymerase at the replication fork during S-phase, or, alternatively, single-strand DNA gaps temporarily remain at the site of base damage and bypass and gap filling occurs after S-phase completion \[[@pgen.1008759.ref007], and references therein\].

In eukaryotes TLS is mediated by Y-family polymerases Polη, Polκ, Polι and Rev1 and the B-family polymerase Polζ, the latter containing a catalytic subunit, Rev3, a regulatory subunit, Rev7 \[[@pgen.1008759.ref008],[@pgen.1008759.ref009]\], as well as accessory subunits \[[@pgen.1008759.ref010]--[@pgen.1008759.ref012]\]. These TLS polymerases lack proofreading activity and have wide catalytic centers to allow for replication across damaged bases and DNA synthesis from misaligned primer termini. These characteristics cause TLS polymerases to have lower fidelity than replicative polymerases, making them inherently error prone. Whereas some types of lesions require only a specific Y-family polymerase, other types require the sequential action of two or more TLS polymerases \[[@pgen.1008759.ref013]--[@pgen.1008759.ref015]\].

While the molecular details of TLS have become better understood it remains unclear how TLS action affects genome maintenance or influences spontaneous mutagenesis either positively or negatively, on a genome-wide scale and in time. The model system *C*. *elegans* is well suited to address these questions for multicellular organisms, because of a condensed genome and the ability for clonal propagation, which makes whole genome sequencing (WGS) practical. In previous studies we have described how *C*. *elegans* Y-family polymerases Polη and Polκ contribute to genomic stability \[[@pgen.1008759.ref016]--[@pgen.1008759.ref018]\]. Here, we investigate the contribution of REV1 and REV3 in suppressing genome alterations, and we address the redundancy between the different TLS enzymes by monitoring mutation accumulation in animals that lack either all *C*. *elegans* Y-family polymerases or all TLS activity. Our study presents the most comprehensive analysis of how TLS activity affects the stability of a genome under non-challenged circumstances.

Results {#sec002}
=======

Generation and characterization of *rev-1* alleles {#sec003}
--------------------------------------------------

To study the role of REV-1 in the maintenance of genomic stability we analyzed several mutant alleles: *rev-1(gk455794)* was generated by the million mutation project \[[@pgen.1008759.ref019]\] and has a point mutation in the acceptor splice site of exon 7, and two early stop alleles were obtained through targeting exon 2 via CRISPR/Cas-9 technology ([S1 Fig](#pgen.1008759.s001){ref-type="supplementary-material"}). We also isolated an allele (named *rev-1BRCT*) containing a G283\>D amino acid substitution in the evolutionarily conserved BRCT domain. G283 of *C*. *elegans* REV-1 aligns to G193 of yeast REV1 and G76 of mice Rev1, which in those species are essential for the functionality of the BRCT domain \[[@pgen.1008759.ref020]--[@pgen.1008759.ref022]\].

All *rev-1* mutant strains had brood sizes and embryonic survival frequencies comparable to wild-type controls ([Fig 1A](#pgen.1008759.g001){ref-type="fig"} and [Fig 1B](#pgen.1008759.g001){ref-type="fig"}), demonstrating that REV-1 is not essential for animal development and fertility under unchallenged conditions. However, similar to REV1 deficient yeast and mES cells \[[@pgen.1008759.ref023]--[@pgen.1008759.ref025]\], REV-1 deficiency in *C*. *elegans* confers hypersensitivity to UV-induced DNA lesions, which manifests as reduced embryonic survival (as compared to wild-type controls) when hermaphrodites are exposed to UV-C ([Fig 1C](#pgen.1008759.g001){ref-type="fig"}). While a similar degree of hypersensitivity is noticed for the three putative knockout alleles, the *rev-1BRCT* allele confers an intermediate phenotype consistent with a partial loss of functionality. This evolutionary conserved UV-hypersensitivity of REV1 deficiency is less dramatic than observed for *C*. *elegans* mutants defective in Polη, another TLS polymerase implicated in the bypass of UV-induced damage \[[@pgen.1008759.ref016],[@pgen.1008759.ref026]\].

![Spontaneous DNA damage and mutagenesis in *rev-1* deficient animals.\
A) Quantification of total brood sizes for different *rev-1* alleles. Each data point represents the total brood of a single hermaphrodite. B) The surviving fraction of progeny was calculated as the number of hatched eggs divided by the brood size. Error bars denote SD. C) Progeny survival in response to UV-C exposure to hermaphrodites of the indicated genotype. Error bars denote SEM. D) Representative images of RAD-51 and DAPI-stained distal tips of *C*. *elegans* gonads. Arrows point to RAD-51 foci. E) Quantification of spontaneous RAD-51 foci in the mitotic compartment of the gonadal arms. Each dot represents the average number for a single mitotic region. Error bars indicate mean with sd (\*\*\* indicates p\<0.001, t-test). F) Molecular descriptions of the mutations found in *unc-93* for the indicated genotype (SNV = single-nucleotide variation, DEL = deletion, DELINS = deletion with insert). The number of SNVs found is indicated between parentheses. The degree of micro-homology found at deletion junctions is indicated between parentheses. For *rev-1* deficient animals 30 revertants were analyzed. Data from REV-1 proficient *unc-93* reversion is retrieved from \[[@pgen.1008759.ref013]\].](pgen.1008759.g001){#pgen.1008759.g001}

REV-1 suppresses the formation of genomic deletions and rearrangements {#sec004}
----------------------------------------------------------------------

When TLS is impaired, replication forks can collapse at sites of base damage and form DSBs. In the mitotic compartment of the *C*. *elegans* gonad, recombinogenic DNA substrates can be visualized by staining for the recombinase RAD-51, which forms foci. While such foci are not found in wild-type animals, both *rev-1*(*gk455794*) as well as *rev-1BRCT* animals had a very small, yet statistically significant number of nuclei in the mitotic zone containing a RAD-51 focus ([Fig 1D](#pgen.1008759.g001){ref-type="fig"} and [Fig 1E](#pgen.1008759.g001){ref-type="fig"}). To address potential mutagenic consequences of elevated levels of replication stress or DNA breaks, as suggested by increased RAD-51 foci formation, we assayed mutation induction in *rev-1* mutants. We first used the phenotype-based *unc-93* reversion assay \[[@pgen.1008759.ref027],[@pgen.1008759.ref028]\]: animals carrying the toxic *unc-93(e1500)* allele have a very poor capacity to move and also grow slower. However, any additional mutation in *unc-93* leading to complete loss of function will lead to reversion of these phenotypes. Loss of function mutations in the suppressor genes *sup-9*, *sup-10*, *sup-11* or *sup-18* will also revert *unc-93(e1500)* animals to wild-type-resembling growth and movement. Picking wild-type-moving worms out of populations of *unc-93* animals, followed by inspection of their genomes thus results in a mutation profile. To establish such profiles, we isolated 30 revertants for each genotype and subsequently sequenced the *unc-93* locus. In WT, *rev-1BRCT* and *rev-1(gk455794)* animals we respectively found 7, 14, and 14 causative mutations in *unc-93*(*e1500*) ([Fig 1F](#pgen.1008759.g001){ref-type="fig"}); the remaining revertant animals likely carry mutations in the suppressor loci, which were not further analyzed. In the WT background, 6 out of 7 mutations were single nucleotide variations (SNVs) that disrupt gene function via amino acid substitution, introduction of an early stop or loss of a splice site; one deletion of 4 bp was found. Similar base substitutions and deletions of few bases were also found in the *rev-1BRCT* mutant, but here, 6 of the 14 mutations were larger deletions (\>50 bp). For *rev-1(gk455794*), all causative mutations (n = 14) were deletions \>50 bp in size. From this data we conclude that REV-1 has an important role in suppressing a specific type of spontaneous mutagenesis, *i*.*e*. the formation of small genomic deletions.

Mutagenic tradeoff by REV-1 action {#sec005}
----------------------------------

While the *unc-93* reversion assay is an established method to study mutagenesis in *C*. *elegans* it has drawbacks. For instance, the mutational target is limited and fixed, and the only mutations that will be picked up are those that disrupt gene function, thus creating a bias: deletions are more likely to disrupt gene function than SNVs. Also, the assay conditions themselves hinder accurate quantifications of mutation rates. To overcome these shortcomings and study spontaneous mutagenesis in a predominantly unbiased and quantitative way, we performed whole-genome sequencing (WGS) of wild-type and *rev-1* mutant animals that were clonally grown for multiple generations ([Fig 2A](#pgen.1008759.g002){ref-type="fig"} and [S1 Table](#pgen.1008759.s004){ref-type="supplementary-material"}; [S2 Table](#pgen.1008759.s005){ref-type="supplementary-material"}). For wild-type animals we found mutation rates to be \~0.23 SNVs, \~0.04 micro-satellite indels, and \~0.04 small deletions per animal generation. While the rate for micro-satellite indels is identical in *rev-1* mutant animals, the SNV rate is lowered; the SNV spectrum, however, was similar, if not identical, to that in wild-type animals ([Fig 2B](#pgen.1008759.g002){ref-type="fig"}). Interestingly, the reduction in SNVs matched an increase in the rate of deletion formation in the \>50 bp size range ([Fig 2A](#pgen.1008759.g002){ref-type="fig"} and [Fig 2C](#pgen.1008759.g002){ref-type="fig"}): we identified 15 cases in *rev-1*(*gk455794*) genomes and 1 in the wild-type control, constituting a changed distribution (p = 0.0032, Mann-Whitney). This outcome leads to the suggestion that base damage requiring REV-1 action is mutagenic both in the presence and absence of REV-1: when bypassed by REV-1-mediated TLS a SNV results, but in REV-1 compromised cells a deletion is the outcome. In addition to simple deletions a limited number of complex rearrangements was found in *rev-1* mutant animals--these were not observed in the analyzed genomes of wild-type animals.

![REV-1 suppresses genomic scars caused by TMEJ, without compensation by other Y-family TLS polymerases.\
A) WGS analysis of wild-type (WT) and *rev-1* deficient animals that were grown for 40--60 generations under unperturbed conditions. Per genotype at least three independent populations were analyzed. Mutations were categorized into five different classes (\*\* indicates p\<0.01, \*\*\* indicates p\<0.001, t-test). B) distribution of SNV types. C) Deletions found in WGS data plotted by size (log10 scale) for both wild-type and *rev-1* deficient animals (\*\* indicates p\<0.01, Mann-Whitney). D) A schematic representation of the genome surrounding the *unc-93* locus on chromosome III. Essential genes are colored blue, the *unc-93* gene is colored black, while other genes are in grey. PCR amplicons used to estimate deletions sizes are indicated in green. Underneath, boxed in red a visual representation of *unc-93* loss of function alleles derived from the indicated genotype. All *unc-93* alleles obtained from *rev-1* animals were determined at nucleotide resolution via Sanger sequencing. For the sizable *unc-93* alleles that accumulated in *rev-1 polq-1* the minimal (red box) and maximal (red dotted line) borders were established. \* denotes animals that did not produce viable progeny, likely due to a homozygous mutation in the essential gene *gsr-1*. E) Progeny survival in response to UV-C exposure to hermaphrodites of the indicated genotype. Error bars denote SEM.](pgen.1008759.g002){#pgen.1008759.g002}

This mutation profile of *rev-1* animals strikingly resembles the ones we previously described for strains deficient in TLS polymerases POLH-1 and POLK-1, as well as for strains defective for the helicase FANCJ/DOG-1 \[[@pgen.1008759.ref017],[@pgen.1008759.ref029],[@pgen.1008759.ref030]\]. Deletion mutagenesis in *polh-1* and *polk-1* strains occur seemingly random throughout the genome, whereas deletions in *dog-1* animals map to sequences that are able to fold into replication-blocking G-quadruplex structures. Deletions in *rev-1* mutant genomes do not map to particular sequence motifs, despite potential indications from genetic analysis in chicken DT40 cells, which demonstrated a function for REV1 in replicating through G-quadruplex structures \[[@pgen.1008759.ref031],[@pgen.1008759.ref032]\]. We also tested potential synergy between *rev-1* and *dog-1* with respect to G-quadruplex stability, but did not find any ([S2 Fig](#pgen.1008759.s002){ref-type="supplementary-material"}).

TMEJ repairs DSBs that result from REV-1 loss {#sec006}
---------------------------------------------

The similarity in the profile of spontaneous mutagenesis in *rev-1* and *polh-1* or *dog-1* points to a causal involvement of polymerase theta-mediated end joining (TMEJ). TMEJ was previously shown in *C*. *elegans* to repair DSBs that arise at replication-impeding base damages or secondary structures \[[@pgen.1008759.ref017],[@pgen.1008759.ref030]\]. Indeed, deletions accumulating in *rev-1* have signature hallmarks of TMEJ: micro-homology at break sites and occasionally inserts that are homologous to sequences in the immediate vicinity of the deletion \[[@pgen.1008759.ref017], [@pgen.1008759.ref030], [@pgen.1008759.ref033], [@pgen.1008759.ref034]\]. To address potential causality with respect to TMEJ involvement we used the *unc-93* reversion assay and determined the molecular nature of the mutations that spontaneously arise in animals mutated for both *rev-1* and *polq-1* (encoding pol theta/Polθ). We indeed found a dramatically changed mutation profile ([Fig 2D](#pgen.1008759.g002){ref-type="fig"}). Instead of the characteristic 50-500bp size, all deletions isolated from *rev-1 polq-1* populations were profoundly larger: none that mapped to the *unc-93* locus retained the 2.5 kb spanning *unc-93* gene; 2 of 5 being \>10 kb and having lost all loci between *unc-93* and the most nearby essential genes. To further asses the notion that TMEJ acts to repair failed TLS of damaged bases, we tested Polθ's involvement in relation to UV-induced DNA lesions. While Polθ deficiency itself does not sensitize otherwise wild-type animals to UV-C, it exacerbates the hypersensitivity of *rev-1* animals ([Fig 2E](#pgen.1008759.g002){ref-type="fig"}).

We conclude that *C*. *elegans* REV-1 prevents DSB-induced deletion mutagenesis during unperturbed growth.

REV-1 independent functions of POLH-1 and POLK-1 {#sec007}
------------------------------------------------

We previously analyzed knockout alleles of *polh-1* and *polk-1*, the genes encoding the other two Y-family polymerases present in the *C*. *elegans* genome: Polη and Polκ \[[@pgen.1008759.ref016], [@pgen.1008759.ref017]\]. While *polh-1* mutants, like *rev-1*, display some spontaneous mutagenesis under non-perturbed growth, *polk-1* mutant animals do not. However, the analysis of animals deficient for both genes revealed profound functional redundancy for these proteins: the marginal deletion mutagenesis observed in *polh-1* mutant animals dramatically increased when also POLK-1 was lost. To investigate whether one of these two TLS polymerases, or both, also provide back-up functions in REV-1 deficient animals (or *vice versa*) we generated *polh-1 polk-1 rev-1* triple mutant animals, which thus lack all Y-family TLS activity (the *C*. *elegans* genome does not encode Polι). Under unchallenged growth conditions, we found brood size and embryonic survival of these so-called "Y-family polymerase dead" mutants to be lower than wild-type, yet remarkably mildly affected ([Fig 3A](#pgen.1008759.g003){ref-type="fig"} and [Fig 3B](#pgen.1008759.g003){ref-type="fig"}). Because of this only mildly disturbed animal fitness we could grow animals for 50 generations to address mutation accumulation, and found that the mutation load in *polh-1 polk-1 rev-*1 mutants is very similar if not identical to that in *polh-1 polk-1* mutants ([Fig 3D](#pgen.1008759.g003){ref-type="fig"} and [S1 Table](#pgen.1008759.s004){ref-type="supplementary-material"}; [S2 Table](#pgen.1008759.s005){ref-type="supplementary-material"}). For comparison we also included our previously published data for *polk-1* and *polh-1* mutant animals, which we re-analyzed using updated software.

![Genome protection by REV-3 and the Y-family of TLS polymerases.\
A) Quantification of total brood size for wild-type, *rev-3*, *rev-1 polh-1 polk-1* and *rev-1 polh-1 polk-1 rev-3* deficient animals. Each data point represents the total brood of a single hermaphrodite. B) The surviving fraction of progeny was calculated as the number of hatched eggs divided by the brood size. Error bars denote SD (\*\* indicates p\<0.01, \*\*\* indicates p\<0.001, t-test). C) Progeny survival in response to UV-C exposure to hermaphrodites of the indicated genotype. Error bars denote SEM. D) WGS analysis of WT and TLS deficient animals grown for 20--60 generations. Per genotype at least three independent populations were analyzed, except for *polh-1* where only two independent populations were analyzed. Error bars denote SD (\* indicates p\<0.05, \*\* indicates p\<0.01, \*\*\* indicates p\<0.001, t-test). E) Size plot for deletions that accumulate in the genomes of the indicated genotypes. Red line represents median size (log10 scale). F) Pie charts visualizing the subdivision of all deletions into three categories: i) simple deletions, ii) templated insertions, which represent deletions carrying insertions that were of sufficient size (≥5bp) to be mapped to their origin in the immediate vicinity of the junctional sequence (\<40bp surrounding the deletion breakpoints), iii) miscellaneous (misc.) insertions, which are deletions that also contain insertions, but which were below 5bp in size, or were of unknown origin. G) Heatmap representations of micro-homology present at deletion junctions, with a schematic representation illustrating the methodology: for every deletion, each position of the upstream breakpoint is compared to each position of the downstream breakpoint. Identical nucleotides score 1, non-identical score 0. Subsequently, a heat map is constructed by summing all scores for all events at each position divided by the number of events. For reference purposes, a heat map was constructed from all (368) deletions in the various genotypes, but with flank sequences shuffled *in silico*. Of note, all alleles are annotated in keeping with maximal 5' conservation, which here dictates that the base at the -1 position at the 5' side is never identical to the +1 position at the 3' side: in such a case, that base will shift to the +1 position at the 5' side. As a consequence of this rule, the position marked by a white square will have no microhomology score, while the +1,-1 position is slightly elevated. The extent of this methodological skewing can be noticed in the analysis of the random set of deletions. Number next to heatmap represents the fraction of micro-homology at the indicated location (NS---non-significant, \*\*\*---p\<0.001, chi-square test compared to random set).](pgen.1008759.g003){#pgen.1008759.g003}

From the observations that REV-1 deficiency brings about only a marginal level of deletion mutagenesis, and does not further enhance the genomic instability in *polh-1 polk-1* animals, we conclude that Polη and Polk redundantly act to bypass spontaneous DNA damage in *C*. *elegans* in a *grosso modo* error-free manner. In such manner, these polymerases do not require the action of REV-1, yet are potentially recruited to sites of DNA damage by PCNA ubiquitylation \[[@pgen.1008759.ref035]\].

REV-1 suppresses genomic deletions through polymerase ζ {#sec008}
-------------------------------------------------------

In addition to direct bypass through catalysis \[[@pgen.1008759.ref036]--[@pgen.1008759.ref039]\], REV1 also plays a non-catalytic role via interactions with other TLS proteins such as Polη and the REV7 subunit of B-family TLS polymerase Polζ \[[@pgen.1008759.ref040]--[@pgen.1008759.ref042]\]. Rev1 and Rev3 mutant cells have similar phenotypes, arguing that Rev1 is especially important for Polζ activity. To address whether the increased deletion mutagenesis in *C*. *elegans rev-1* mutants is a consequence of Polζ disfunction, we analyzed *rev-3* mutant animals. A putative null allele, *rev-3*(*gk919715)*, generated by the million mutation project, contains a nonsense mutation in exon 3 producing an early stop N-terminal of all relevant functional domains. ([S1 Fig](#pgen.1008759.s001){ref-type="supplementary-material"}). Subsequent to extensive backcrosses in order to remove background mutations, we measured a reduced brood size, but no embryonic lethality for *rev-3*(*gk919715)* ([Fig 3A](#pgen.1008759.g003){ref-type="fig"} and [Fig 3B](#pgen.1008759.g003){ref-type="fig"}). To validate a TLS deficiency in this genetic background, we exposed hermaphrodites to UV-C, and found hypersensitivity of progeny embryos comparable to the hypersensitivity observed for *rev-1* mutants ([Fig 3C](#pgen.1008759.g003){ref-type="fig"}). Animals deficient for both REV-1 and REV-3 are as sensitive as either single mutant indicating no role for REV-1 outside Pol ζ in bypass of UV-induced damage. We next grew multiple *rev-3* mutant lines clonally for 50 generations after which their genomes were sequenced ([S1 Table](#pgen.1008759.s004){ref-type="supplementary-material"}; [S2 Table](#pgen.1008759.s005){ref-type="supplementary-material"}). We found that SNVs and indels at microsatellite repeats accumulate at the same rate in REV-3 proficient and deficient animals ([Fig 3D](#pgen.1008759.g003){ref-type="fig"}), arguing that REV-3-dependent TLS on spontaneous lesions does not cause substantial numbers of point mutations or that backup mechanisms are equally or more mutagenic. However, and similar to the genomes of clonally propagated *rev-1* mutant animals, a clear increase can be detected for deletions of size 50-500bp. This category of mutations, the product of TMEJ action on DNA breaks, are thus observed in all animals with compromised TLS, *i*.*e*. *polh-1*, *rev-*1 and *rev-3*, except in *polk-1* where POLH-1 can completely compensate for loss of POLK-1 ([Fig 3D](#pgen.1008759.g003){ref-type="fig"} and [Fig 3E](#pgen.1008759.g003){ref-type="fig"}). This class of deletions, with a narrow size range of 50-500bp, bears the typical signature of polymerase theta action upon DNA break repair: the occasional presence of templated insertions, and an overrepresentation of micro-homology at the deletion junction ([Fig 3F](#pgen.1008759.g003){ref-type="fig"} and [Fig 3G](#pgen.1008759.g003){ref-type="fig"}). In all these backgrounds also more complex events were found: a collection of inversions, tandem duplications or events that are more complex and classify into the umbrella term gross chromosomal rearrangements.

Loss of TLS activity is compatible with *C*. *elegans* development and fertility {#sec009}
--------------------------------------------------------------------------------

The observation that *rev-3* mutant animals have similar levels of deletion mutagenesis as *rev-1* mutant animals, together with the outcome that *rev-1* loss did not significantly elevate the genomic instability observed in *polh-1 polk-1* mutants predicts that *polh-1 polk-1 rev-1 rev-3* quadruple mutant animals can be generated, which are hence devoid of any TLS activity. Indeed, we found that the brood size and embryonic survival of these "TLS-dead" mutants, although lower than WT, is only mildly affected; animals also develop normally ([Fig 3A](#pgen.1008759.g003){ref-type="fig"} and [Fig 3B](#pgen.1008759.g003){ref-type="fig"}). We next determined the long-term genetic effects by monitoring mutational accumulation upon prolonged culturing ([Fig 3D](#pgen.1008759.g003){ref-type="fig"} and [Fig 3E](#pgen.1008759.g003){ref-type="fig"}, [S1 Table](#pgen.1008759.s004){ref-type="supplementary-material"}, [S2 Table](#pgen.1008759.s005){ref-type="supplementary-material"}). We found that *polh-1 polk-1 rev-1 rev-3* quadruplex mutant animals, similar to *rev-1* single mutant animals, displayed a reduced SNV mutation rate as compared to wild-type animals. However, the overall mutagenesis rate is greatly elevated, because of an approximately 30-fold increase in deletion mutagenesis, similar to the level observed in *polh-1 polk-1* animals ([Fig 3D](#pgen.1008759.g003){ref-type="fig"}). This net increase in the mutational load in TLS-abolished conditions argues that bypass of endogenous lesions in TLS proficient animals is predominantly error-free. Of note, the observation that loss of REV-1 and REV-3 does not further increase the genomic instability observed in the *polh-1 polk-1*, argues that Polζ does not bypass endogenous replication fork barriers independent of Polη or Polκ ([Fig 3D](#pgen.1008759.g003){ref-type="fig"}). Our data also suggests that the contribution of REV-1, as a scaffold, or REV-3, as an extender, is limited in the bypass of spontaneous and UV-induced DNA damage.

Genome scarring in TLS deficient *C*. *elegans* is preferential at guanine bases {#sec010}
--------------------------------------------------------------------------------

In an effort to deduce the molecular nature of the replication fork impediment from the mutation accumulation data we examined the base composition of deletion junctions. Previous work, analyzing deletions formed at replication-blocking G-quadruplexes, revealed that at least one of the breakpoints maps very close, if not immediately adjacent, to the replication impediment \[[@pgen.1008759.ref030]\]. We reasoned that this may also occur at spontaneous lesions in TLS-compromised animals: one could argue that the nascent strand, which is extended by the replicative polymerases right up to the blocking lesion is a substrate for TMEJ when TLS cannot occur and thus defines one border of a deletion ([Fig 4A](#pgen.1008759.g004){ref-type="fig"}). According to this logic, the first deleted base at the junction will frequently represent the nucleotide that is complementary to the damaged base. To assess this idea, we have determined the normalized base distribution at the deletion junctions for each genetic background. Because the total numbers of deletions in each single mutant was too low for statistically supported conclusions, we processed the data derived from *polh-1 polk-1*, *polh-1 polk-1 rev-1* and *polh-1 polk-1 rev-1 rev-3* mutant animals. In all three genetic backgrounds we detect a non-random distribution, *i*.*e*. a significant enrichment for cytosines at the -1 position ([Fig 4B](#pgen.1008759.g004){ref-type="fig"} and [S3B Fig](#pgen.1008759.s003){ref-type="supplementary-material"}; [S3D Fig](#pgen.1008759.s003){ref-type="supplementary-material"}). This outcome is consistent with the idea that TLS is required predominantly at guanines to suppress replication-associated DSBs. Damaged guanines as the primary source for the deletion junctions also explains the apparent enrichment of cytosines at more downstream positions (-2 until -6) because TMEJ itself frequently results in loss of a few nucleotides at one or both sides of a DSB and micro-homology usage in TMEJ also perturbs correct annotation of the deletion junction (*e*.*g*. three different annotations are possible for a deletion with 2 bases of micro-homology) \[[@pgen.1008759.ref034]\], which together dilutes underlying mechanistic parameters. We therefore also analyzed a subset of deletions for which such potential disturbing effects are reduced, *i*.*e*. deletions with insertions (see \[[@pgen.1008759.ref034]\] for details). Using this subset, we indeed found the enrichment for cytosines at position -1 more pronounced ([Fig 4C](#pgen.1008759.g004){ref-type="fig"} and [S3C Fig](#pgen.1008759.s003){ref-type="supplementary-material"}; [S3E Fig](#pgen.1008759.s003){ref-type="supplementary-material"}).

![Failure to bypass damaged guanines results in deletions.\
A) Schematic illustration of the concept that one junction of DNA-damage-induced deletions is defined by the nascent strand blocked at sites of DNA damage. In this hypothesis, the replication-blocking lesion may dictate position -1, being the outermost nucleotide of the lost sequence. B) The base composition of all deletion breakpoints, normalized to the relative AT/CG content around the breakpoints (from +100 to -100). Position 100 to 1 reflects the sequence that is retained in the deletion alleles; position -1 to -100 reflects the sequence that is lost. Dashed lines represent three times the SD. Data points outside these boundaries are marked with an enlarged dot. C) as in B, but now only for deletions with insertions.](pgen.1008759.g004){#pgen.1008759.g004}

Discussion {#sec011}
==========

When the first eukaryotic factors of TLS (Rev1, Rev3 and Rev7) were characterized in yeast they were found to promote both induced and spontaneous mutagenesis. Here, we show that lack of TLS polymerases leads to an increase in the overall mutational load in *C*. *elegans* grown under unperturbed conditions, implying that TLS action suppresses mutagenesis. The major causes for the mutagenicity of TLS are the "hard-to-read" character of bulky lesions, the wider catalytic centers of TLS polymerases (allowing for less stringent base pairing), and the lack of proofreading. In bacteria and yeast, template switching provides an error-free alternative to TLS, which may explain the lower mutation rate in TLS deficient mutants \[[@pgen.1008759.ref043],[@pgen.1008759.ref044]\]. While such a mechanism may be present in higher eukaryotes as well, its importance remains unclear \[[@pgen.1008759.ref045]\]. Here, we have analyzed the contribution of TLS activity on long-term genetic stability in *C*. *elegans*. We monitored fitness and spontaneous mutagenesis in animals deficient for REV1, for REV3, for all Y-family TLS enzymes, and for all TLS activity. We found that *C*. *elegans* REV-1 and REV-3 both safeguard survival in *C*. *elegans* upon exposure to UV light but are not needed for development and reproduction under unchallenged conditions in a laboratory environment. To our surprise, we found that TLS is not essential for animal life as TLS-dead animals proliferate and produce morphologically normal progeny. While we found evidence for alternative processing of blocked replication, by means of TMEJ of DNA breaks, other biology may also contribute to the mild consequences of a complete TLS deficiency. For instance, when occurring in germline nuclei, DNA breaks can be repaired by homologous recombination, or DSB-containing nuclei can be removed through apoptosis. We found that Y-family-dead and TLS-dead animals accumulate mutations over generations at the same rate and with the same characteristics as *polh-1 polk-1* mutant animals, while the increase in mutation accumulation in *rev-1* or *rev-3* animals is only minor, which argues that Polη and Polκ i) act redundantly to bypass the vast majority of spontaneous DNA damage in *C*. *elegans*, ii) act in an error-free manner, and iii) do not require the action of REV-1 nor REV-3 for most lesions. The comprehensive mutation profiles we present for different TLS compromised *C*. *elegans* strains support the idea that TLS is anti-clastogenic and we infer from our data that the most common endogenous replication blocks reside at guanines, which in the absence of TLS generate replication-associated DSBs that are repaired by polymerase theta-mediated end joining. This DSB repair pathway is intrinsically mutagenic, hence genome scars that are characterized by micro-homology are predicted to occur at sites where replication blocks persist. Of interest, such scars are also observed in tumors deficient for the breast cancer genes BRCA1 and BRCA2 (COSMIC mutational signature ID6). In those genetic contexts potential replication-dependent DSBs cannot be repaired in an error-free manner by homologous recombination and depend on alternative routes for their repair.

We found that deficiencies for REV-1 and REV-3 lead to very similar mutation profiles and UV-hypersensitivity, which supports the hypothesis that these proteins may act in concert. Their requirement during unchallenged *C*. *elegans* growth, however, is small: in their absence, \~0.1 deletion per generation is found, which, considering 10--15 cell divisions per generation argues that only 1 lesion per 10^10^ bases depends on REV-1 and REV-3 to be bypassed. The consequences of REV-1 or REV-3 loss in more complex animals is more detrimental. While REV1 deficient mouse embryonic fibroblasts, yeast and human fibroblast cell lines have no proliferative problems, Rev1^-/-^ mice develop poorly \[[@pgen.1008759.ref025], [@pgen.1008759.ref045]--[@pgen.1008759.ref048]\]. REV3 is essential for mammalian development: missense mutations in the human REV3L gene can cause Mobius syndrome which is associated with developmental abnormalities \[[@pgen.1008759.ref049]\], and Rev3 knockout mice are embryonic lethal \[[@pgen.1008759.ref050]\]. The fact that we do not observe such profound developmental and reproduction defect in worms may be explained by a low damage load and by the relatively small size of the *C*. *elegans* genome. Indeed, we found very low levels of spontaneous DSBs in *rev-1* deficient worms. Such replication-associated DSBs do not induce noticeable proliferative defects likely because they are, at least in part, repaired by TMEJ.

Another explanation for lack of viability in mammals when REV1 or REV3 function is lost may in part reside in functions outside TLS: in biology that may not be evolutionarily conserved. For instance, we cannot formally rule out a proposed role for Rev1 in homologous recombination but we have not found experimental support: defective HR in *C*. *elegans* results in reduced brood size, substantial or complete embryonic lethality and X-chromosomal non-disjunction \[[@pgen.1008759.ref051]\], which we did not observe for *rev-1* mutants. Also, we have not found indications supporting a role for *C*. *elegans* REV-1 in replicating through G-quadruplex structures, as was observed in DT40 chicken B-lymphocyte cells \[[@pgen.1008759.ref031],[@pgen.1008759.ref032]\]. *C*. *elegans* REV1 and REV3 proteins are substantially smaller than their mammalian counterparts and lack amino acids sequences, such as REV1's C-terminal domain, that manifest positive evolutionary selection pressure in vertebrates.

The frequency of deletion formation in the TLS-dead mutants may also provide an indication of how often a replication fork runs into an insurmountable block for the replicative polymerases in the context of a multicellular organism. In fact, if one assumes that in a TLS-dead mutant context every lesion that cannot be bypassed forms a deletion of \>50bp, it becomes clear how rare spontaneous replication blocks are. In an estimated 10--15 rounds of replication per generation only 1 deletion occurs. For a genome of 10^8^ bases, this means that only 1 in \~10^9^ bases requires TLS for its replication.

All our data point to damaged guanines as the predominant spontaneous lesion that requires TLS. Interestingly, OGG1, the glycosylase that in many other biological systems removes the majority of abundantly induced 8-oxo-G lesions via BER (reviewed in \[[@pgen.1008759.ref052]\]), is not encoded by the *C*. *elegans* genome. This lack of repair together with this lesion being an efficient and accurate TLS substrate \[[@pgen.1008759.ref053]\] may provide an explanation for this strong base effect. It is, however, not the case that the spontaneous mutations in *C*. *elegans* are predominantly G to A (or C to T) transitions, nor have we found a dramatic reduction of these types of mutations in TLS deficient worms. Together, our observations argue that the genome is *grosso modo* devoid of base damage when it is replicated, explaining the lack of TLS-induced mutations as well as the ability to reproduce when all TLS activity is lost. Despite the low damage load, we find that in absence of TLS the overall mutagenic consequence is strongly increased as small deletions (50 to 500 bp) manifest, which by virtue of being ORF disrupting have a more detrimental outcome than TLS--induced SNVs.

From our studies, we thus conclude that TLS in *C*. *elegans* not only protects replication potential, it also protects the genome against the formation of small genomic deletions and larger complex rearrangements and thereby helps to maintain genome stability on an evolutionary scale. These predominantly beneficial outcomes of TLS activity provides selective advantages for the presence of these specialized polymerases in all living organisms \[[@pgen.1008759.ref008]\].

Material & methods {#sec012}
==================

C. elegans genetics {#sec013}
-------------------

All strains were cultured according to standard methods \[[@pgen.1008759.ref054]\]. The N2 Bristol strain was used as WT control. The alleles *polq-1(tm2026)*, *rev-1(gk455794)*, *unc-91(e1500)* were obtained from the Caenorhabditis Genetics Center, Minnesota, USA. *The rev-1(BRCT)* allele was isolated via a random mutagenesis approach described in \[[@pgen.1008759.ref055]\]. The *rev-1(lf206)* and *rev-1(fl207)* KO alleles were obtained via CRISPR/Cas9-mediated genome editing as described below in further detail.

CRISPR/Cas9 mediated generation of *rev-1* null alleles {#sec014}
-------------------------------------------------------

For CRISPR/Cas9 mediated targeting we used the following sequence (which includes the PAM site) in exon 2 of *rev-1*: AGTTTCATCCTCTTCGTCACTGG. Cloning was done as described in \[[@pgen.1008759.ref056]\]. Plasmids were injected using standard *C*. *elegans* microinjection procedures. In brief, 1 day before injection, L4 animals were transferred to new plates and cultured at 15 degrees. Gonads of young adults were injected with a solution containing 20 ng/μl pDD162 (Peft-3::Cas9, Addgene 47549), 20 ng/μl pMB70 (u6::sgRNA with *rev-1* target, 10 ng/μl pGH8, 2.5 ng/μl pCFJ90 and 5 ng/μl pCFJ104. Progeny (F1) animals that express mCherry were picked to new plates 3--4 days post injection and allowed to produce offspring. Of each F1 plate 10 F2 animals were pooled, lysed and genotyped. Genotyping was done by PCR amplification of a 480 bp product around the CRISPR/Cas9 target site. Subsequent restriction with MaeIII enzyme of the wild-type sequence would result in 2 fragments (91 bp + 389 bp). A mutation at the target site can disrupt the MaeIII recognition site resulting in an uncut PCR product. We isolated 4 alleles, 2 of which were small out-of-frame deletions ([S1 Fig](#pgen.1008759.s001){ref-type="supplementary-material"}).

Brood size and embryonic lethality assay {#sec015}
----------------------------------------

To determine the brood size, we singled L4 animals on OP50 plates. Every day for four days, we transferred the mother to a fresh plate and one day later quantified the number of embryos and larvae on the plate. We quantified the broods and embryonic lethality of \> 20 animals per genotype.

Survival assays {#sec016}
---------------

To measure germline sensitivity to UV, staged young adults (one day post L4) were transferred to empty NGM plates and exposed to different doses of UV-C. Per dose and genotype 3 plates with 3 adults were set up using NGM plates with OP50 and allowed to lay eggs for 24 hours. Subsequently adults were discarded and the brood on the plate was allowed to hatch. 24 hours later the number of non-hatched eggs and surviving progeny was determined.

Sample preparation, RAD-51 antibody staining, imaging and quantification {#sec017}
------------------------------------------------------------------------

Animals were synchronized by picking L4 stage worms 22h before dissection. Worms were dissected in 1x EBT (25 mM HEPES-Cl pH 7.4, 118 mM NaCl, 48 mM KCl, 2 mM CaCl~2~, 2 mM MgCl~2~, 0.1% Tween 20 and 20 mM sodium azide) to expose gonads. Most of the buffer was removed and the sample with cover glass was transferred to a Superfrost Plus slide and flash frozen on a metal block in dry ice. Upon complete crystallization of the sample the cover glass was quickly removed (freeze-cracking) followed by post-fixation in 4% PFA in 1x EBT. After washing, the samples were incubated with RAD-51 antibody (rabbit polyclonal from SDIX/Novus Biologicals, cat\# 29480002, used at 1:1000 in PBST+0.5%BSA) overnight at room temperature. Alexa anti-rabbit 488, 1:500, was used as secondary antibody and incubated for 2h at room temperature. DNA was stained 10 min in 0.5 μg/ml DAPI/PBST. Finally, samples were de-stained in PBST for 1 h and mounted with Vectashield. Imaging and processing was done on a Leica DM6000 microscope. The data obtained ([Fig 1D](#pgen.1008759.g001){ref-type="fig"} and [Fig 1E](#pgen.1008759.g001){ref-type="fig"}) are from at least 3 independent experiments. Each data point represents an average value of the mitotic zone of one gonad.

Mutation accumulation lines and whole genome sequencing {#sec018}
-------------------------------------------------------

Mutation accumulation lines were generated by cloning out F1 animals from one homozygous hermaphrodite, generating subpopulations. Each generation three worms from each subpopulation were transferred to new plates. MA lines were maintained for on average 45 generations. Single animals were then cloned out and propagated to obtain full plates for DNA isolation. Worms were washed off with M9 and incubated for 2 hours while shaking to remove bacteria from the intestines. Genomic DNA was isolated using a Blood and Tissue Culture Kit (Qiagen). DNA was sequenced on an Illumina HiSeq machine according to manufacturer's protocol. Image analysis, base calling and error calibration were performed using standard Illumina software. Raw reads were mapped to the C. elegans reference genome (Wormbase release 235) by BWA \[[@pgen.1008759.ref057]\]. GATK's HaplotypeCaller \[[@pgen.1008759.ref058]\] was used for SNV calling. To identify larger indels and microsatellites, GATK \[[@pgen.1008759.ref057]\] and Pindel \[[@pgen.1008759.ref059]\] were used. In cases that only one program identified the structural variation, visual inspection was carried out using IGV \[[@pgen.1008759.ref060]\]. Variations were marked as true if i) it is a *de novo* variation, thus all other subpopulations did not support the variation. ii) covered by both forward and reverse reads, iii) covered at least five times. Mutation rates for different variations are calculated as the number of mutations per sample divided by the number of generations grown. See [S1 Table](#pgen.1008759.s004){ref-type="supplementary-material"} for mutation rates and [S2 Table](#pgen.1008759.s005){ref-type="supplementary-material"} for all identified *de novo* variations.

G4 stability on qua1466 {#sec019}
-----------------------

Qua1466 is a genomic sequence \[[GGG]{.ul}A[GGG]{.ul}C[GGG]{.ul}C[GGG]{.ul}\] located on chromosome IV (location 11,326,500--11,326,514) that can potentially form a G-quadruplex structure. To assay genomic instability and the formation of deletions at this site we performed a nested PCR reaction on lysed animals using the following primers: external forward CAAATAAGTATTGGGCCGAAACC; external reverse AAGGAACACCTTCAAGACTCC, internal forward CTGCGAACTTCTGACGAATTTG, internal reverse TTGACTCCTCCTCTTCTGGC. As template for the external PCR 1 μl of a 15 μl lysis with 5 worms was used. 0.5 μl of the external PCR was used as template for internal PCR. 10 μl of internal PCR product was run for 1 hour at 120V on a 1% agarose gel.

*unc-93 (e1500)* mutagenesis assay {#sec020}
----------------------------------

To pick up spontaneous mutations in the *rev-1(gk455794)* and *rev-1(gk455794) polq-1(tm2026)* backgrounds, we used a mutagenesis assay based on reversion of the so-called ''rubber band" phenotype, caused by a dominant mutation in the muscle gene *unc-93*. Reversion of the *unc-93(e1500)* phenotype is caused by homozygous loss of *unc-93(e1500)* or one of the suppressor genes *sup-9*, *sup-10*, *sup-11*, *and sup-18*. For both genotypes, *rev-1 unc-93(e1500)* and *rev-1; polq-1(tm2026); unc-93(e1500)*, 400 animals were singled on 9 cm plates. These plates were grown until starvation and of each plate an equal amount (chunks of 2 x 2 cm) were transferred to fresh 9 cm plates. Before these plates reached starvation they were inspected for wild-type moving animals. From each starting culture, only one revertant animal was isolated to ensure independent events. Of each genetic background we randomly selected 30 revertants and sequenced the *unc-93* gene. When large deletions occurred we established the approximate size of the deletion with PCR amplicons of approximately 500 bp located at the borders of the gene and 2.5 kb and 5 kb up and downstream of the *unc-93* gene.

Supporting information {#sec021}
======================

###### Schematic representations of all TLS polymerase genes encoded in *C*. *elegans* and the mutations used in this study.

A\) *rev-1*, B) *polh-1*, C) *polk-1* and D) *rev-3*.

(PDF)

###### 

Click here for additional data file.

###### *rev-1* does not aggravate G-quadruplex deletions in *dog-1* deficient animals.

Nested PCR was performed on genomic G4 site qua1466 (expected size: 1000bp). 5 adult worms per well lysed in 15 ul lysis buffer. 1ul lysis per well was used as a template for a nested PCR. No additional genomic instability was observed in *dog-1* deficient animals after loss of REV-1. M denotes DNA marker. Wells were scored as positive when one or more bands appeared \<1000bp. Empty wells were not included in the quantification.

(PDF)

###### 

Click here for additional data file.

###### Failure to bypass damaged guanines results in deletions.

A\) Schematic illustration of the concept that one junction of DNA-damage-induced deletions is defined by the nascent strand blocked at sites of DNA damage. In this hypothesis, the replication-blocking lesion may dictate position -1, being the outermost nucleotide of the lost sequence. B-C) The base composition of all deletion breakpoints, normalized to the relative AT/CG content around the breakpoints (from +100 to -100) in *polh-1 polk-1* (B) and *polh-1 polk-1 rev-1* (C). Position 100 to 1 reflects the sequence that is retained in the deletion alleles; position -1 to -100 reflects the sequence that is lost. Dashed lines represent three times the SD. Data points outside these boundaries are marked with an enlarged dot. D) as in B, but now only for deletions with insertions. E) as in C, but now only for deletions with insertions.

(PDF)

###### 

Click here for additional data file.

###### Mutagenesis rates in *C*. *elegans* TLS mutants.

(XLSX)

###### 

Click here for additional data file.

###### Mutation profiles derived from *C*. *elegans* whole genome sequencing data.

(XLSX)

###### 

Click here for additional data file.

Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440).
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**Comments to the Authors:**

**Please note here if the review is uploaded as an attachment.**

Reviewer \#1: Bostelen et al. investigate the consequence of translesion synthesis polymerases in mutagenesis in C. elegans. Translesion synthesis (TLS) polymerases are required for replicating DNA amid damaged bases. Studies in yeast and bacteria have established that TLS polymerases are error prone. Bostelen et al. now have analyzed TLS polymerase mutants in C. elegans to better understand to which extend they are responsible for replication-associated mutagenesis in metazoan.

They start with the analysis of several alleles of rev-1 that confer UVC hypersensitivity but are dispensable for fitness under unperturbed laboratory conditions even though RAD-51 foci indicative of DSB formation were elevated in replicating germ cells. Single nucleotide variants (SNVs) were reduced while deletion number and size were strongly elevated in rev-1 mutants. Furthermore, embryonic lethality of polq-1 is exacerbated by a rev-1 mutation. However, the deletion frequency of polh-1;polk-1 double mutants was not altered by a rev-1 mutation and rev-1 and rev-3 were epistatic. Analysis of the deletion sequence revealed that particular C at -1 position were enriched indicating that deletions occurred amid damaged guanines.

Taken together, the authors provide a thorough mutation analysis of TLS polymerases that establish that they primarily protect the genome from deletions in C. elegans. Their study makes an important contribution to better understand the consequences of TLS particularly in the metazoan context and will be of interest to the community across the fields of DNA repair, replication, and genetics.

Specific comments:

1\. It would be helpful if the authors could summarize their analyses of mutations per generation in a table that would also include literature data as comparison as some of the single TLS mutants are referred to in the literature and not analyzed again here.

2\. SD should be used instead of SEM whenever distinct populations (e.g. mutant vs. wildtype) are compared.

Reviewer \#2: The manuscript by van Bostelen and colleagues investigates the role of translesion synthesis in genome stability using C. elegans as a model system. Continuing from their previous results, the authors monitored the fitness, DNA damage resistance and spontaneous mutagenesis in strains mutant for individual TLS polymerase genes, or their combinations. According to their somewhat surprising findings, rev1 and rev3 knockouts only weakly influence spontaneous mutagenesis. The generation of SNVs is reduced in the rev1, but not in the rev3 mutant (in contrast with yeast), and there is an increase in the formation of \>50bp deletions, but this increase is moderate compared to the simultaneous knockout of polh and polk.

The data shed new light on the relative roles of TLS polymerases in causing base substitution mutations, and in protecting from DNA breaks. The manuscript also contains a number of useful specific observations, for example that deletions (and the originating DNA breaks) may initiate precisely at the sites of damaged bases, as suggested by the sequence preference of the start of deletions. The analysis is of good quality, with little to add.

The main weakness of the approach is that in the small worm genomes very few mutations arise, even after many generations. For example, the SNV mutation spectra in fig.1B cannot be accurately compared due to the very low number of events, and the SNV numbers are also not sufficient to generate 'triplet' mutation spectra and compare them to cancer-derived mutation signatures. It would have been very useful had the authors chosen to sequence a larger number of animal lineages.

Further comments:

Introduction: When listing the TLS polymerases, please also make a mention of the TLS role of pol delta, especially PolD3 (see e.g. PMID: 25628356).

p6 Fig. 1F unc-93 reversion assay: again, it would be great to have some more sequences. The authors should also analyse the context of the deletions, specifying if they show microhomology.

p9: The polh polk rev1 triple mutant had marginally fewer mutations than the polh polk double mutant, indicating a weak role for rev1 in this background. But considering that a major function of rev1 is the recruitment of other Y family polymerases rather than DNA synthesis, this could also be an epistatic relationship. The recruitment role of rev1 is discussed in the next section, but only with respect to pol zeta. It is possible that rev1 is needed for both polh/polk recruitment and polz recruitment, and both of these are needed for lesion bypass according to the two-polymerase model.

Alternatively, the explanation for the much stronger phenotype of the polh polk double mutant compared to rev1 or rev1 rev3 could suggest that polh and polk are primarily recruited through a rev1-independent mechanism, presumably PCNA ubiquitylation. This mechanism has been investigated recently (PMID: 31450086) and should be discussed.

In the discussion, please further emphasise that the results are C. elegans specific, and compare and contrast them with yeast and vertebrate data where available. Please compare the spectrum of deletions in the TLS mutants to the recently published COSMIC version 3 indel signatures.

Importantly, there needs to be a supplementary table for the WGS data, showing the precise number of worms/worm populations sequenced, the number of generations, the number and classification of mutations in each sample, and the list of mutations (with chromosomal position) for each sample. I cannot find any of this information in the manuscript. It is not sufficient to share the raw sequence files.

It would also be useful to show a summary of the mutation data in a simple table in the text. Currently these data are split to numerous graphs, with different scales, making comparisons difficult.

These tables should also include previously published data that was re-analysed here.

The doi link of ref 17 is incorrect.

Reviewer \#3: Review of von Bostelen et al 2020

In this work, the authors build on their prior work analyzing viability, UV sensitivity and mutation frequency and spectrum in C. elegans mutants lacking translesion synthesis (TLS) polymerase activities and/or proteins. In previous work , they had analyzed a subset of single and double mutants lacking activity of TLS polymerases. Here, they add analysis of mutants lacking Y-family polymerase REV1 and/or the REV3 catalytic subunit of the B-family TLS polymerase, as well as mutants deficient for activities of: 1) all Y family polymerases, or 2) all TLS polymerases. They show that most animals lacking Y or all TLS polymerases are viable, but accumulate spontaneous deletions (with or without associated insertions) with size ranges distinct from those seen in wild-type worms and with signatures that are suggestive of repair of DSBs via a microhomology-mediated end-joining pathway (TMHEJ). Further, they provide indirect evidence, based on an excess of C residues adjacent to the likely site of DNA breakage inferred from deletion breakpoint analyses, suggesting that guanine adducts are the predominant types of lesions whose repair depends on TLS polymerases. In addition, an observed increase in mutation frequency in TLS-null or Y-polymerase null mutants suggests that repair mediated by TLS polymerases in the C. elegans germ line is substantially error free.

Overall, the experiments and analyses presented here are largely sound and well documented, and the topic is certainly appropriate for PLoS Genetics. However, the work is substantially weakened by statements made throughout the manuscript that conflate actual experimental findings with interpretations. That is, the authors claim to have demonstrated Y, when in fact they have actually demonstrated X, and Y is the favored interpretation. This failure to make rigorous distinctions between: a) experimental results and b) interpretations and conclusions based on the results is problematic for several reasons. It is misleading to more naïve readers who may not recognize the conflation, and it is also misleading to busy expert readers who may assume that a different type of assay must have been performed in order to reach the stated conclusion. For example, the authors have a tendency to make statements that would appear to require biochemistry to support them. The authors must be careful to articulate their conclusions in a manner that aligns with the actual assays performed and the type of data from which they are derived.

The above-described problem, while pervasive and serious, can be addressed almost entirely by textual revisions. Many instances are flagged here, but please note that this listing is not comprehensive, and the authors should make appropriate revisions throughout the manuscript.

Title:

"suppress genome scarring at sites of base damage"

It is true that TLS polymerases (collectively) suppress formation of spontaneous deletions. However, it has not been demonstrated that the inferred breaks that give rise to the deletions occur at sites of base damage.

Abstract:

It is shown that the TLS polymerases antagonize the formation of deletions, but the idea that they prevent DSBs from occurring is an indirect inference. And again, the idea that breaks are occurring at sites of base damage is hypothesized based on biochemistry in other systems, but it not demonstrated here; nor is directly demonstrated that guanine adducts are the main source of DNA damage requiring TLS for bypass (see comments below regarding discussion), although the data are consistent with this interpretation. Statements made in the abstract must make a clear distinction between what is shown, and what are (likely) interpretations supported by the data. It is entirely appropriate to interpret data in light of a model, as long as the distinctions are clear.

The last sentence seems like an odd closer given the statement just prior that TLS in C. elegans is predominantly error free- can the authors articulate: where is the risk that needs to be outweighed?

Results:

P5 l 102-109: 1) cannot equate RAD-51 foci with DSBs; RAD-51 foci do NOT necessarily represent DSBs, as RAD-51 can also associate with other types of lesions, e.g. ss gaps.

2\) "apparently, these spontaneous DSBs do not affect proliferation..." Based on the info provided, one cannot assume repair- if lesions such as breaks or extensive ss DNA persisted into meiotic prophase, they would almost certainly be detected by DNA damage checkpoints and eliminated by apoptosis. Note that the authors could potentially test whether apoptosis is elevated in these mutants, but given that it is estimated that \>50 of oogenic germ cell nuclei are eliminated during WT meiosis, even if there were a significant increase in nuclei harboring unrepaired DNA lesions, this might not be sufficient to move the needle on apoptosis frequency. The best thing to do here would be to simply remove the problematic narrative and jump into the compelling evidence for altered mutation profiles.

P6, Fig 1:

l 108, state "asked whether mutation induction is elevated"- but while the assay in this section evaluates mutation profile, insufficient information about mutation frequency is provided here. Please elaborate on effects on mutation frequency, or if there are concerns that the unc-93 mutation assay was performed in a way that would not provide reliable information regarding frequency, modify the set-up and other text to focus this section on mutation profile.

Statistically analysis (e.g. Fisher exact test) evaluating the relative numbers of SNPs vs indels among the unc-93 mutations from WT vs revBRCT mutant indicate that there is not statistical support to conclude that the mutation profiles are different.

"From this data we conclude.....bypass of endogenous lesions": This is NOT a lesion bypass assay, please align conclusion with the assay.

"... role in SUPRESSING spontaneous mutagenesis LIKELY by suppressing the formation..."

P7 Fig 2

Please provide more information (could be in Figure legend or methods) regarding how mutation rates were deduced from the mutation accumulation lines.

L 145 "...identified 15 cases..." Here, the point scan actually be made more strongly- rather than calling out specifically one deletion size class, the authors can point out that the whole size distribution is very different (2C), a result with very strong statistical support with Mann-Whitney test (p value should be provided). Suggest stating: "There is both an increase in the incidence of deletions and a substantial difference in the size distributions of the deletions observed."

L148 To be able to make a statement about a class of mutations being present in one genotype but absent in another, need to provide information about the numbers and to address whether there is statistical support for there being a real difference between genotypes.

P8 l 175-178

Here the set-up narrative is flawed- one can conclude that repair of UV-induced lesions in the absence of REV1 is Pol theta dependent, CONSISTENT WITH...(interpretation).

P9 L194. Here, and elsewhere (and possibly in the Discussion), the authors need to consider the possibility that elimination of damage-containing cells via apoptosis could profoundly affect the embryonic survival metric; at a minimum, they need to discuss this issue as it is relevant to the conclusion that TLS polymerases are non-essential.

L199-202. Avoid making statements when there is not statistical support.

Fig 2F-H, Fig 3 (all except G and maybe F)

To facilitate comparisons among these genotypes, the data in these panels should be consolidated so that there is one graph of each type:

Brood size

Survival

UV sensitivity

Mutations/generation

Deletion sizes

(Possibly Indel type pie charts, although those could be deferred to the next figure.)

(It is ok if not all genotypes are represented in every graph type)

The narrative in the Results section can still consider subsets of the data sequentially as the picture is being built up, as in the current version.

Fig 3G

3G and 3 F could potentially stand alone as a figure by themselves (new Fig 4), or they could be the last 2 panels of the new revised Fig 3,

However it is done, that the heat map for the random in silico generated deletions should be the same size as the real data for better comparison. Also, the actual values in the +1 -1 position should be indicated below the graph for each genotype and random. Finally, some evidence regarding whether there is statistical support for microhomology should be provided. One simple way would be to use a Chi-square test to assess, for the +1 -1 position, whether the incidences of same vs different nucleotide in the real deletions observed for each genotype differ from those expected for random. (Based on the visual representation and low numbers for rev3 single mutant, there may not be statistical support for this genotype; if that turns out to be the case, the text should be revised appropriately.)

P 10 L234-5. Change order of sentence to avoid semantic ambiguity: ""...repair, micro-homology at the deletion junction (G) and the occasional presence of...(F)"

P 11 L253-5. This sentence is too definitive- need alternative wording that doesn't overstate. E.g. need to consider/discuss the possibility that more lesions might form under these mutant conditions, and/or if this is considered unlikely, explain why.

P 11 L261. Section heading is too definitive- even though it is a reasonable explanation for the result, the section heading should state the finding, not the interpretation.

Discussion:

P 12 The discussion opens with the statement that TLS polymerases in yeast were found to "promote both induced and spontaneous mutagenesis"

HERE, the authors show that LACK of TLS polymerases apparently increases mutagenesis, implying that the TLS polymerases (as least as a cohort) INHIBIT mutagenesis. This apparent contrast should be addressed explicitly and head-on.

P13 L308 -314. This is a model, with features that are consistent with the data. The authors need to more clearly distinguish between what is shown and models that are supported by the findings.

The data clearly show that the TLS polymerases are anti-clastogenic. They also show that Cs are overrepresented adjacent to deletion junctions. These data are consistent with a model in which: 1) breaks that give rise to the observed deletions tend to occur at or near the sites of damaged bases that cause replication blockage and 2) damaged Gs are the most common replication blockages that require TLS polymerases for their bypass.

The discussion of amounts of spontaneous DSBs on P 14 completely ignores the possibility of elimination of cells with DSBs by apoptosis and/or use of HR to repair such breaks. These are relevant to the discussion, as both HR and DNA damage checkpoints are highly active in the germline.

I'm a bit confused by the last sentence of the discussion- hasn't it already been argued that bypass using the TLSs in C. elegans is predominantly error free ( based on an increase in overall mutation frequency when they are absent)? If so, where is the trade-off?

\*\*\*\*\*\*\*\*\*\*

**Have all data underlying the figures and results presented in the manuscript been provided?**

Large-scale datasets should be made available via a public repository as described in the *PLOS Genetics* [data availability policy](http://journals.plos.org/plosgenetics/s/data-availability), and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.
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Dear Dr Tijsterman,

We are pleased to inform you that your manuscript entitled \"Translesion synthesis polymerases are dispensable for C. elegans reproduction but suppress genome scarring by polymerase theta-mediated end joining\" has been editorially accepted for publication in PLOS Genetics. Congratulations!

Please note that Reviewers \#2 and \#3 had a couple of helpful suggestions (see below) that you might want to consider as you prepare your final draft for the production team (the editorial team will not need to re-evaluate).

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional accept, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you've already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at <plosgenetics@plos.org>.

In the meantime, please log into Editorial Manager at <https://www.editorialmanager.com/pgenetics/>, click the \"Update My Information\" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to 'Update my Information' (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about one way to make your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!
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Julie Ahringer
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**Comments to the Authors:**

**Please note here if the review is uploaded as an attachment.**

Reviewer \#1: The authors adequately addressed all my comments.

Reviewer \#2: I thank the authors for the changes and have no further scientific comments.

Minor issues:

I suggest adding a colour key to the new Figure 3D panel.

Fred Sanger did not write his name with an umlaut (Fig. 2 legend).

Reviewer \#3: This revision very nicely addresses the issues raised in the previous review. I especially appreciate how much easier it was to digest and compare the information for different mutant genotypes in the newly consolidated Figure 3. I am happy to recommend acceptance of this revised manuscript.

In preparing the final files for publication, please address the following:

1\) Add color key to Fig 3D graph

2\) Several remaining typos (e.g. "Off note", on line 245) or small grammatical errors in the manuscript text. Since PLoS Genetics does not use a copy editor, it will be helpful to have a fresh pair of eyes to catch these.
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Large-scale datasets should be made available via a public repository as described in the *PLOS Genetics* [data availability policy](http://journals.plos.org/plosgenetics/s/data-availability), and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.
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If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the [Dryad Digital Repository](http://www.datadryad.org). As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our [website](http://journals.plos.org/plosgenetics/s/data-availability#loc-recommended-repositories).

The following link will take you to the Dryad record for your article, so you won\'t have to re‐enter its bibliographic information, and can upload your files directly: 

<http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-20-00260R1>

More information about depositing data in Dryad is available at <http://www.datadryad.org/depositing>. If you experience any difficulties in submitting your data, please contact <help@datadryad.org> for support.
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If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper\'s publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there\'s anything the journal should know or you\'d like more information, please get in touch via <plosgenetics@plos.org>.
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